Cours Capstone Therapeutics Corp Other OTC
Actions
US14068E1091
Recherche biotechnologique et médicale
CA 2022 | 61,56 M 56,04 M | CA 2023 | 48,35 M 44,02 M | Capitalisation | 820 k 746 k |
---|---|---|---|---|---|
Résultat net 2022 | 2 M 1,82 M | Résultat net 2023 | -3 M -2,73 M | VE / CA 2022 | 0,56 x |
Dette nette 2022 | 28,78 M 26,2 M | Dette nette 2023 | 20,28 M 18,46 M | VE / CA 2023 | 0,44 x |
PER 2022 |
-583
x | PER 2023 |
-0,14
x | Employés | - |
Rendement 2022 * |
-
| Rendement 2023 |
-
| Flottant | 100% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Michael Toporek
CEO | Chief Executive Officer | 59 | 14/07/17 |
Edward Schultz
DFI | Director of Finance/CFO | - | - |
Matthew Lipman
BRD | Director/Board Member | 45 | 14/07/17 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Jock Holliman
BRD | Director/Board Member | 70 | 01/09/87 |
Michael Toporek
CEO | Chief Executive Officer | 59 | 14/07/17 |
Matthew Lipman
BRD | Director/Board Member | 45 | 14/07/17 |
Varia. 1 janv. | Capi. | |
---|---|---|
+1,63% | 42,75 Md | |
+47,70% | 41,61 Md | |
+12,11% | 41,34 Md | |
-8,83% | 26,59 Md | |
+7,21% | 25,49 Md | |
-23,07% | 18,12 Md | |
+29,99% | 12,24 Md | |
-2,27% | 11,76 Md | |
+8,26% | 11 Md |